The Lynx Group
  • Home
  • About
  • Contact
  • Issue Archive
  • Special Issues
  • Supplements
Personalized Medicine in Oncology
Subscribe

Subscribe Today!

To sign up for our newsletter or print publications, please enter your contact information below.

I'd like to receive:

Menu
  • PMO Interview with the Innovator Series
  • Conference Correspondent
    • NSCLC IO 2022 – Midyear Review
    • Dual IO 2021
    • AACR & ASCO 2021 – Midyear Review
    • ASCO 2020
  • Web Exclusives
    • Rapid Reactions
    • FDA Approvals, News & Updates
    • Press Releases
  • Videos
    • NTRK Gene Fusions
    • 2018 AONN Midyear
    • 2018 ASCO Insights
    • The Biomarker
  • PMO Interview with the Innovator Series
  • Conference Correspondent
    • NSCLC IO 2022 – Midyear Review
    • Dual IO 2021
    • AACR & ASCO 2021 – Midyear Review
    • ASCO 2020
  • Web Exclusives
    • Rapid Reactions
    • FDA Approvals, News & Updates
    • Press Releases
  • Videos
    • NTRK Gene Fusions
    • 2018 AONN Midyear
    • 2018 ASCO Insights
    • The Biomarker
  • Home
  • About
  • Contact
  • Issue Archive
  • Special Issues
  • Supplements

Sitemap

  • About
  • Author Flip
  • Author Guidelines
  • Call for Abstracts – Submission Guidelines
  • Conference Correspondents
  • Contact
  • Continuing Education
  • Editorial Board
  • Events
  • Fifth Annual World Cutaneous Malignancies Congress
    • Agenda*
    • CE Info
    • Conference Faculty
    • Registration
    • Submit a Topic for the Fifth Annual World Cutaneous Malignancies Congress
  • Home
  • In the News
  • Legacy Flip
  • Mechanism of Action
  • Press Releases
  • Privacy Policy
  • Sandbox
  • Special Issues
  • Sponsor
  • Submit an Abstract
  • Subscribe
  • Supplements
  • Thank You
  • Thank You for Submitting Your Abstract
  • Thank You For Subscribing!
  • Virtual Conferences
    • 2013 World Cutaneous Malignancies Congress Virtual Conference
    • Fourth Annual PMO Live Virtual Conference
    • Second Annual Global Biomarkers Consortium Clinical Approaches to Targeted Technologies
In the News
    May 19, 2016

    Two-pronged attack on chemotherapy-resistant leukemia cells

    May 18, 2016

    An Early Look at Research From the 2016 ASCO Annual Meeting

    May 18, 2016

    Drug against breast cancer is also highly potent against a frequent form of leukaemia

    May 17, 2016

    Improving natural killer cancer therapy: Study

Sign me up!

Copyright 2023. The Lynx Group, LLC. All Rights Reserved. Privacy Policy. Sitemap.

By continuing to browse this site, you agree to our use of cookies.